BIOGEN INC
BIIBNASDAQ$244.05▼ $8.67 (−3.43%)
🌙 After hours$244.55▲ 0.20%Regular close · extended-hours price shownTrack BIIB
Get earnings, price moves & breaking news on Telegram
24h▼ 3.4%
7d▼ 3.9%
14d▲ 3.7%
30d▲ 7.5%
ytd▲ 38.7%
1y▲ 64.7%
🏦Market Cap
$36.06B
Mid Cap
📈Revenue Growth (YoY)
1.4%
Slowing
📊Gross Margin
70.0%
High
💵FCF Margin
22.8%
Strong
⚖️P/S Ratio
3.5x
Fair
Otter Score
76
Strong
BIOGEN INC
BIIBAnalyst Ratings
Price
$244.05
Total
49
Raised
8
Lowered
7
Avg PT
$245.63
H / L
$300 / $175
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Reiterated | Equal Weight | 2026-10-28 | $185.00 | −24.20% |
B of A Securities | Reiterated | Neutral | 2026-10-22 | — | — |
TD Cowen | Reiterated | Buy | 2026-10-21 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-10-20 | $250.00 | +2.40% |
JP Morgan | Upgraded | Neutral → Overweight | 2026-10-12 | — | — |
UBS | Reiterated | Buy | 2026-10-09 | $270.00 | +10.60% |
RBC Capital | Reiterated | Outperform | 2026-10-08 | $256.00 | +4.90% |
HSBC | Reiterated | Reduce | 2026-09-10 | $175.00 | −28.30% |
Piper Sandler | Reiterated | Overweight | 2026-09-03 | $245.00 | +0.40% |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2026-08-13 | $300.00 | +22.90% |
Mizuho | Reiterated | Outperform | 2026-08-04 | — | — |
Citigroup | Reiterated | Neutral | 2026-08-03 | $160.00 | −34.40% |
Morgan Stanley | Reiterated | Equal Weight | 2026-07-30 | $231.00 | −5.30% |
Canaccord Genuity | Reiterated | Buy | 2026-07-30 | $248.00 | +1.60% |
Wedbush | Reiterated | Neutral | 2026-07-30 | $201.00 | −17.60% |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-30 | — | — |
Guggenheim | Reiterated | Buy | 2026-07-21 | $280.00 | +14.70% |
Truist Securities | Upgraded | Hold → Buy | 2026-07-13 | — | — |
Needham | Reiterated | Buy | 2026-06-29 | $255.00 | +4.50% |
Oppenheimer | Reiterated | Outperform | 2026-04-01 | $300.00 | +22.90% |
Freedom Broker | Reiterated | Hold | 2026-02-23 | — | — |
BMO Capital | Reiterated | Market Perform | 2026-02-09 | $220.00 | −9.90% |
Stifel | Upgraded | Hold → Buy | 2025-11-06 | — | — |
Bernstein | Reiterated | Market Perform | 2025-11-03 | $191.00 | −21.70% |
Baird | Reiterated | Outperform | 2025-05-02 | — | — |
Goldman Sachs | Reiterated | Buy | 2025-04-23 | $225.00 | −7.80% |
Argus Research | Downgraded | Buy → Hold | 2025-04-04 | — | — |
Scotiabank | Reiterated | Sector Outperform | 2025-02-13 | $275.00 | +12.70% |
Jefferies | Downgraded | Buy → Hold | 2024-12-09 | $190.00 | −22.10% |
Cantor Fitzgerald | Reiterated | Overweight | 2024-09-09 | — | — |
Raymond James | Upgraded | Market Perform → Outperform | 2023-12-07 | $315.00 | +29.10% |
Atlantic Equities | Reiterated | Neutral | 2023-08-08 | $295.00 | +20.90% |
Cowen & Co. | Reiterated | Outperform | 2023-02-16 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-10-26 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2021-06-08 | — | — |
Credit Suisse | Reiterated | Outperform | 2021-02-04 | — | — |
DZ Bank | Upgraded | Hold → Buy | 2020-11-10 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-04-23 | — | — |
Nomura | Reiterated | Buy | 2020-02-07 | — | — |
Standpoint Research | Downgraded | Buy → Hold | 2019-11-01 | — | — |
Piper Jaffray | Downgraded | Overweight → Neutral | 2019-06-28 | — | — |
Stifel Nicolaus | Downgraded | Buy → Hold | 2019-02-21 | $242.00 | −0.80% |
Argus | Downgraded | Buy → Hold | 2018-02-16 | — | — |
H.C. Wainwright | Reiterated | Buy | 2018-01-26 | $251.00 | +2.80% |
Bank of America | Reiterated | Buy | 2017-10-18 | — | — |
Leerink Swann | Downgraded | Outperform → Market Perform | 2017-03-16 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2016-11-07 | — | — |
Deutsche Bank | Reiterated | Buy | 2014-07-24 | — | — |
FBR Capital | Reiterated | Outperform | 2013-10-02 | — | — |
Institution
Barclays
Reiterated · Equal Weight · 2026-10-28
$185.00
−24.20%
B of A Securities
Reiterated · Neutral · 2026-10-22
—
—
TD Cowen
Reiterated · Buy · 2026-10-21
—
—
Wells Fargo
Reiterated · Overweight · 2026-10-20
$250.00
+2.40%
JP Morgan
Upgraded · Neutral → Overweight · 2026-10-12
—
—
UBS
Reiterated · Buy · 2026-10-09
$270.00
+10.60%
RBC Capital
Reiterated · Outperform · 2026-10-08
$256.00
+4.90%
HSBC
Reiterated · Reduce · 2026-09-10
$175.00
−28.30%
Piper Sandler
Reiterated · Overweight · 2026-09-03
$245.00
+0.40%
Wolfe Research
Upgraded · Peer Perform → Outperform · 2026-08-13
$300.00
+22.90%
Mizuho
Reiterated · Outperform · 2026-08-04
—
—
Citigroup
Reiterated · Neutral · 2026-08-03
$160.00
−34.40%
Morgan Stanley
Reiterated · Equal Weight · 2026-07-30
$231.00
−5.30%
Canaccord Genuity
Reiterated · Buy · 2026-07-30
$248.00
+1.60%
Wedbush
Reiterated · Neutral · 2026-07-30
$201.00
−17.60%
HC Wainwright & Co.
Reiterated · Buy · 2026-07-30
—
—
Guggenheim
Reiterated · Buy · 2026-07-21
$280.00
+14.70%
Truist Securities
Upgraded · Hold → Buy · 2026-07-13
—
—
Needham
Reiterated · Buy · 2026-06-29
$255.00
+4.50%
Oppenheimer
Reiterated · Outperform · 2026-04-01
$300.00
+22.90%
Freedom Broker
Reiterated · Hold · 2026-02-23
—
—
BMO Capital
Reiterated · Market Perform · 2026-02-09
$220.00
−9.90%
Stifel
Upgraded · Hold → Buy · 2025-11-06
—
—
Bernstein
Reiterated · Market Perform · 2025-11-03
$191.00
−21.70%
Baird
Reiterated · Outperform · 2025-05-02
—
—
Goldman Sachs
Reiterated · Buy · 2025-04-23
$225.00
−7.80%
Argus Research
Downgraded · Buy → Hold · 2025-04-04
—
—
Scotiabank
Reiterated · Sector Outperform · 2025-02-13
$275.00
+12.70%
Jefferies
Downgraded · Buy → Hold · 2024-12-09
$190.00
−22.10%
Cantor Fitzgerald
Reiterated · Overweight · 2024-09-09
—
—
Raymond James
Upgraded · Market Perform → Outperform · 2023-12-07
$315.00
+29.10%
Atlantic Equities
Reiterated · Neutral · 2023-08-08
$295.00
+20.90%
Cowen & Co.
Reiterated · Outperform · 2023-02-16
—
—
SVB Leerink
Reiterated · Outperform · 2022-10-26
—
—
William Blair
Upgraded · Market Perform → Outperform · 2021-06-08
—
—
Credit Suisse
Reiterated · Outperform · 2021-02-04
—
—
DZ Bank
Upgraded · Hold → Buy · 2020-11-10
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-04-23
—
—
Nomura
Reiterated · Buy · 2020-02-07
—
—
Standpoint Research
Downgraded · Buy → Hold · 2019-11-01
—
—
Piper Jaffray
Downgraded · Overweight → Neutral · 2019-06-28
—
—
Stifel Nicolaus
Downgraded · Buy → Hold · 2019-02-21
$242.00
−0.80%
Argus
Downgraded · Buy → Hold · 2018-02-16
—
—
H.C. Wainwright
Reiterated · Buy · 2018-01-26
$251.00
+2.80%
Bank of America
Reiterated · Buy · 2017-10-18
—
—
Leerink Swann
Downgraded · Outperform → Market Perform · 2017-03-16
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2016-11-07
—
—
Deutsche Bank
Reiterated · Buy · 2014-07-24
—
—
FBR Capital
Reiterated · Outperform · 2013-10-02
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space